0 NASDAQ Companies - March 1, 2019European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal AgentRead More
0 NYSE Companies - March 1, 2019TransCanada’s Mountaineer XPress project placed into service, Gulf XPress reaches partial in-serviceRead More
0 NYSE Companies - March 1, 2019Bellatrix Provides Update on Its Ongoing Debt Refinancing EffortsRead More
0 NASDAQ Companies - March 1, 2019Kforce Enters Into Agreement to Sell Its Federal Government Solutions BusinessRead More
0 NASDAQ Companies - March 1, 2019TG Therapeutics, Inc. Announces Final Phase 2 Multiple Sclerosis Data Presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Annual MeetingRead More
0 NASDAQ Companies - March 1, 2019Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business UpdateRead More
0 NASDAQ Companies - March 1, 2019Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial ResultsRead More
0 NASDAQ Companies - March 1, 2019Astec Industries Appoints Mary L. Howell to Board of DirectorsRead More
